They must be going off the old adage of no news is good news but the reality is the market would respond better hearing about each patient successfully completing the trial rather than vague updates where we have to interpret each announcement (which each poster interprets differently I should add). I would love to top up at this share price but it's a flip of the coin whether a trial complete or capital raising announcement comes first.
Ann: Half-Year Investor Presentation, page-44
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
